Finland· FI-REL-REL8031
Hct-Sal
A hydrochlorothiazide product, registered in Finland by SALMED. The same ATC class is registered in 16 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Hydrochlorothiazide is registered in 16 of 19 countries.
Countries holding a registration under ATC C03AA03 (hydrochlorothiazide), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 9 of them publish a price we can compare per daily dose
Hydrochlorothiazide · ATC C03AA03
16 / 19 countries
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of hydrochlorothiazide costs, country by country.
Normalised to the WHO defined daily dose (25 mg), the median price runs from $0.048 in France to $0.21 in Switzerland — a ×4.4 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Hydrochlorothiazide · price per daily dose (25 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.21
- IT Italy$0.075
- FR France$0.048
The record
At a glance
Fimea (Finland)- Manufacturer
- SALMED
- Country
- Finland (FI)
- ATC code
- C03AA03
- ATC class
- Hydrochlorothiazide
- Defined daily dose
- 25 mg, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
490 interactions on record for hydrochlorothiazide.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Hydrochlorothiazide · interactions on record
490 records
- 4 severe
- 208 moderate
- 21 minor
- 169 info
Most severe, free to view
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- Aminolevulinic acidL01XD04severe
- Arsenic trioxideL01XX27severe
88 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under C03AA03
Hydrochlorothiazide, as other registers publish it.
- CanadaAPO-HYDROCHLOROTHIAZIDEAPOTEX INC
- CanadaAPO-HYDROCHLOROTHIAZIDEAPOTEX INC
- CanadaAPO-HYDROCHLOROTHIAZIDEAPOTEX INC
- FinlandDichlotrideMerck Sharp & Dohme B.V.
- SwitzerlandEsidrex
- NorwayEsidrexLaboratoires Juvisé Pharmaceuticals
- ItalyESIDREXLABORATOIRES JUVISE' PHARMACEUTICALS
- FranceESIDREX 25 mg, comprimé sécableLABORATOIRES JUVISE PHARMACEUTICALS
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b30dd86e-91e0-48cb-9c2e-9b3826b7a3b0 GET /v1/drugs/b30dd86e-91e0-48cb-9c2e-9b3826b7a3b0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "25",
"form": "tabletti",
"route": null,
"ddd_unit": "mg",
"strength": "12.5 mg",
"atc_label": "hydroklooritiatsidi",
"ma_number": "8168",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL8031",
"authorised_at": "1981-05-27"
}See everything about hydrochlorothiazide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.